Is post-exposure prophylaxis affordable?
Pinkerton
S D
SD
Holtgrave
D R
DR
Kahn
J G
JG
D019380:Anti-HIV Agents / Q000191:economics* / Q000627:therapeutic use; D002487:Centers for Disease Control and Prevention, U.S.; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D012747:Sexual Partners; D014481:United States
D019380:Anti-HIV Agents